Advised on behavioral health integration strategies within a Medicare Advantage population, specifically to manage co-morbid substance use disorder in medically complex patients. Developed cross-functional models for clinical consultation, collaborative care (CoCM), and digital engagement to reduce total cost of care while improving clinical outcomes.

Partnered with the founding team of a stealth-stage company to define clinical use cases for generative AI in psychotherapy. Advised on team-building, product-market fit, and go-to-market strategy design to ensure alignment with clinical best practices and ethical standards.

Guided the executive team on clinical model and protocol development, go-to-market strategy, and strategic partnerships.

Supported the founding team and investors in business model ideation, product strategy, go-to-market, and customer acquisition strategy.

Collaborated with the innovation arm of a leading investment management firm to evaluate new models of care delivery. Contributed clinical expertise to diligence processes, product incubation, and early-stage company formation in behavioral and integrated care.